Position & Policy Statements

Representing eye physicians and surgeons from coast to coast, the Canadian Ophthalmological Society (COS) advocates for optimal eye care for all Canadians, in part through the publication of the following position and policy statements:

Evidence-based clinical practice guidelines for the periodic eye examination in children aged 0-5 years in Canada

Annexe (December 2019)

Read Now

Canadian Glaucoma Society evidence-based recommendations for the risk of acute angle closure glaucoma with routine use of hyoscine-n-butylbromide (Buscopan) for gastroenterological procedures

(November 2019)

Read Now

Joint position paper calling for a complete ban on scleral tattooing and eyeball jewellery implantation in Manitoba

(September 2018)

Read Now

Advisory statement regarding light therapy (photobiomodulation) for macular degeneration

(October 2019)

Read Now

Use of nonpowder projectile weapons, including Airsoft, BB, nerf, paintball, and pellet guns

(July 2019)

Read Now

Sustained funding to ensure access to anti-vascular endothelial growth factor drugs

Read Now

Medical use of cannabis for dry eye disease

(November 2018)

Read Now

COS and Canadian Corneal, External Disease and Refractive Surgery Society statement to CTV/W5

(April 2019)

Read Now

Statement by the Canadian Ophthalmological Society (COS) Regarding Diversity and Inclusion

(April 2019)

Read Now

Medical use of cannabis for glaucoma

(October 2018)

Read Now

Micro-invasive or minimally invasive glaucoma surgery

(December 2017)

Read Now

Effects of electronic screens on children’s vision and recommendations for safe use

Read Now

Cuban treatment for retinitis pigmentosa

Read Now

COS privacy policy statement

(November 2017)

Read Now

Guidelines for refractive surgery advertising

(March 2013)

Read Now

Orthokeratology & myopia

(June 2012)

Read Now

Valuation of uninsured services

(June 2016)

Read Now

Vision standards for driving in Canada

Read Now